Skip to main content

Advertisement

SpringerLink
Log in

Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes

  • Clinical Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To report the results of scleral buckling (SB) with or without photocoagulation (PC) and intravitreal bevacizumab (IVB) for stage 4 retinopathy of prematurity (ROP) eyes.

Methods

Forty-two eyes of 28 patients with SB and/or PC or IVB were studied. Twenty-nine eyes had stage 4A and 13 eyes had stage 4B ROP. Seventeen eyes underwent SB combined with additional intraoperative or postoperative treatments (combined group). Twenty-five eyes underwent SB without additional therapy (non-combined group). The concentrations of vascular endothelial growth factor (VEGF) in the aqueous humor determined by enzyme-linked immunosorbent assay were compared between the two groups. The initial and final reattachment rates were also compared.

Results

The gestational age and birth weight were 25.0 ± 2.0 weeks and 786 ± 222 g in the combined group, and 25.5 ± 2.1 weeks and 899 ± 315 g in the non-combined group. The postmenstrual age at the time of initial surgery was 38.0 ± 1.9 in the combined and 44.1 ± 4.0 weeks in the non-combined group (P < 0.001). The initial reattachment rate was 92 % in stage 4A and 75 % in stage 4B of ROP eyes in the combined group, and the rate was 93 % in stage 4A and 33 % in stage 4B of ROP eyes in the non-combined group. The mean VEGF concentration in aqueous humor was 1923 ± 779 pg/ml in the combined group and 985 ± 303 pg/ml in the non-combined group (P < 0.05).

Conclusion

Our results show that the retinal reattachment rate after combined therapy was comparable to that in the non-combined group. We conclude that combined therapy may be effective even in ROP eyes with high activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Early Treatment of Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity. Results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684–94.

    Article  Google Scholar 

  2. Capone A Jr, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology. 2001;108:2068–70.

    Article  PubMed  Google Scholar 

  3. Hartnett ME, Maguluri S, Thompson HW, Mccolm J. Comparison of retinal outcomes after sclera buckle or lens-sparing vitrectomy for stage 4 retinopathy of prematurity. Retina. 2004;24:753–7.

    Article  PubMed  Google Scholar 

  4. Prenner JL, Capone A, Trese MT. Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity. Ophthalmology. 2004;111:2271–3.

    Article  PubMed  Google Scholar 

  5. Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T, et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol. 2008;92:1450–5.

    Article  CAS  PubMed  Google Scholar 

  6. Stone J, Chan-Ling T, Pe’er J, Itin A, Gnessin H, Keshet E. Role of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1996;37:290–9.

    CAS  PubMed  Google Scholar 

  7. Nonobe NI, Kachi S, Kondo M, Takai Y, Takemoto K, Nakayama A, et al. Concentration of VEGF in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab. Retina. 2009;29:579–85.

    Article  PubMed  Google Scholar 

  8. Hinz BJ, de Juan E, Repka MX. Scleral buckling surgery for active stage 4A retinopathy of prematurity. Ophthalmology. 1998;105:1827–30.

    Article  CAS  PubMed  Google Scholar 

  9. The Laser ROP Study Group. Laser therapy for retinopathy of prematurity. Arch Ophthalmol. 1994;132:76–80.

    Google Scholar 

  10. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol. 1996;114:1085–91.

    Article  Google Scholar 

  11. Sonmez K, Drenser KA, Capone A Jr, Trese MT. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Ophthalmology. 2008;115:1065–70.

    Article  PubMed  Google Scholar 

  12. Mintz-Hittner HA, Kennedy KA, Chuang AZ. BEAT-ROP cooperative group. Efficacy of intravitreal bavacizmab for stage 3 + retinopathy of prematurity. N Engl J Med. 2011;364:603–15.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Sato T, Wada K, Arahori H, Kuno N, Imoto K, Iwahashi-Shima C, et al. Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol. 2012;153:327–33.

    Article  CAS  PubMed  Google Scholar 

  14. Azuma N, Ishikawa K, Hama Y, Hiraoka M, Suzuki Y, Nishina A. Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am J Ophthalmol. 2006;142:636–43.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Professor Duco Hamasaki of the Bascom Palmer Eye Institute of the University of Miami for his critical discussion and final manuscript revision. This work was supported by JSPS KAKENHI Grant Number 23390401.

Conflicts of interest

Y. Futamura, None; T. Asami, None; N. Nonobe, None; S. Kachi, None; Y. Ito, None; Y. Sato, None; M. Hayakawa, None; H. Terasaki, None.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan

    Yukiko Futamura, Tetsu Asami, Norie Nonobe, Shu Kachi, Yasuki Ito & Hiroko Terasaki

  2. Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan

    Yoshiaki Sato & Masahiro Hayakawa

Authors
  1. Yukiko Futamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsu Asami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Norie Nonobe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shu Kachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yasuki Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshiaki Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masahiro Hayakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroko Terasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yukiko Futamura.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Futamura, Y., Asami, T., Nonobe, N. et al. Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes. Jpn J Ophthalmol 59, 378–388 (2015). https://doi.org/10.1007/s10384-015-0401-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-015-0401-5

Keywords

Search

Navigation